R+D
Collaborative projects
ACINETOCLINIC is a project focused on completing the transition to human clinical development stage (Phase I in healthy volunteers) of the first universal vaccine against infections caused by the antibiotic-resistant bacterium Acinetobacter baumannii. ACINETOCLINIC is funded by the 2016 RETOS-COLABORACIÓN program of the Ministry of Economy, Industry and Competitiveness and co-financed by the FEDER